Abstract:Purpose: In this study, we empirically investigate the impact of the COVID-19 pandemic on China's stock price volatility during and after its initial outbreak, using time-series daily data covering the period from July to October, 2020 and 2021, respectively. Design/Methodology/Approach: In the estimation, the ARDL bounds test approach was employed to examine the existence of co-integration and the relationship of long-run and short-run between the new infection rates and stock price volatility, as stable and unstable variables are mixed. The inner-day and inter-day volatility, based on the Shanghai (securities) composite index, are estimated in separate empirical models. In addition, the Inter-bank overnight lending rate (IBOLR) is controlled in order to consider the effect of liquidity and investment cost. Findings and Implications: We find that in the initial year (2020) of the epidemic, the new infection rate is negatively correlated to stock prices in the short-term, whereas no significant evidence existed in the long-term, regardless of model specifications. However, after the epidemic's outbreak (2021), the result depicts that new infections increased stock prices in the long-term, and depressed its inner-day volatility in the short-term, which is inconsistent with most investigations. This phenomenon may be due to the fact that investors were more concerned about the withdrawal of monetary easing and fiscal stimulus, which were introduced to fight against the epidemic's impact on economy, than the epidemic itself. This study complements the limitations of most existing studies, which just focus on the period of the epidemic's outbreak, and provides insight into macroeconomic policy making in the era of the post COVID-19 epidemic such as the structural and ordered exit of the stimulating policies, intervention in IBOLR and balance social and economic sustainability.

COVID-19 and Stock Market Volatility

Time-varying effects of the COVID-19 pandemic on stock markets and economic activity: evidence from the US and Europe

How COVID-19 has affected stock market persistence? Evidence from the G7's

COVID-19 and instability of stock market performance: evidence from the U.S.

The nexus between COVID-19 fear and stock market volatility

Impact of the COVID-19 Pandemic on China's Stock Market Volatility, During and After the Outbreak: Evidence From an ARDL Approach

The risk transmission of COVID-19 in the US stock market

Introducing the GVAR-GARCH model: Evidence from financial markets

Unleashing the pandemic volatility: A glimpse into the stock market performance of developed economies during COVID-19

Impact of COVID-19 Cases, Deaths, Stringency and Vaccinations on the US Stock Market

Impact of COVID-19 on financial returns: a spatial dynamic panel data model with random effects

The Effect of COVID-19 on Cryptocurrencies and the Stock Market Volatility -- A Two-Stage DCC-EGARCH Model Analysis

Coronavirus and the Chinese Stock Market: Pandemic Versus Financial Crisis

To what extent does COVID-19 drive stock market volatility? A comparison between the U.S. and China

In search of COVID-19 and stock market behavior

Investor sentiments and stock markets during the COVID-19 pandemic

Explaining stock markets' performance during the COVID‐19 crisis: Could Google searches be a significant behavioral indicator?

The Financial Derivatives Market and the Pandemic: BioNTech and Moderna Volatility

Quantifying the impact of COVID-19 on the US stock market: An analysis from multi-source information

The Asymmetric Effect of COVID-19 Pandemic on the US Market Risk Premium: Evidence from AEGAS-M Model

COVID-19 Pandemic and Romanian Stock Market Volatility: A GARCH Approach